MEA Blood Group Typing Market

Middle East & Africa Blood Group Typing Market Size & Growth (2023 to 2028)

The MEA blood group typing market size was valued at USD 0.23 billion in 2023 and is poised to reach USD 0.35 billion by 2028, to grow at a CAGR of 8.25% during the forecast period 2023 to 2028.

Major growth drivers of the MEA blood group typing market include:

• Increasing demand for a blood group in prenatal testing.
• An increasing number of road accidents.
• Emergencies and trauma require blood transfusions.
• The growing number of donated blood.

Blood group tests have gained clinical acceptance due to the increasing blood transfusion rate worldwide.

The demand for blood transfusions will determine the blood group market trends for the foreseeable future.

Blood group typing is a mandatory testing procedure before blood transfusions to measure the blood compatibility of the donor and recipient's blood compatibility and determine the Rh factor. Blood group typing finds applications in prenatal and forensic testing for blood transfusions due to more cases of traffic accidents and blood and related products analysis. These factors aim to facilitate market growth during the forecast period.

The strong growth can be attributed to the increasing prevalence of chronic diseases and the increased R&D activities focusing on understanding the molecular basis of blood and antigen-antibody interactions.

Factors such as strict regulatory requirements for blood transfusions and the risk of infectious diseases such as hepatitis B and HIV may hinder the growth of the global blood group market. Moreover, a lack of knowledge and trained professionals leads to a decrease in sales of blood bank reagents and a market restriction for blood group typing during the forecast period mentioned above.

This research report on the MEA Blood Group Typing Market has been segmented and sub-segmented into the following categories.

By Product: 

• Consumables 
  • Antisera Reagents
  • Red Blood Cell Reagents
  • Anti-Human Globulin Reagents
  • Blood Bank Saline
• Instruments
• Services

By Test Type: 

• ABO
• Antigen
• Antibody Screening
• Cross Matching
• HLA

By Technique: 

• Assay
• PCR
• Microarray
• Massively Parallel Sequencing

By End User: 

• Hospitals
• Clinical Laboratories
• Blood Banks

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the MEA Blood group typing market has a small market share globally because of the availability of favorable reimbursement policies and the growing occurrence of chronic conditions in the region. However, according to World Health Organization (WHO), in 2019, 44% of blood donations came from high-income countries.

The UAE Blood group typing market dominates the MEA Blood group typing market due to its well-developed healthcare industry and growing government initiatives for the healthcare industry.

The Saudi Arabia blood group typing market is predicted to rise significantly due to the increasing incidence of infectious diseases, a significant concern in this region, driving the market's growth.

The South African blood group typing market is expected to grow steadily over the projected period due to reimbursement for various surgeries. In addition, the rising number of accidents & injury cases in countries in South Africa is predicted to lead to the adoption of these tests in the region. However, the lowest revenue share is due to a lack of awareness and debilitating health infrastructure.

The Egypt blood group typing market is expected to grow at the fastest CAGR due to the increasing prevalence of chronic diseases requiring blood group typing over the forecast period.

KEY MARKET PLAYERS

Some of the key companies dominating the MEA Blood group typing market profiled in the report are Bio-Rad Laboratories, Inc., Grifols, S.A., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, Immucor Inc., BAG Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.,